内皮機能不全の世界市場 2020年：企業別、地域別、種類・用途別

• 英文タイトル：Global Endothelial Dysfunction Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：D005-00368 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、内皮機能不全の世界市場を広く調査・分析し、今後の市場展望をまとめております。内皮機能不全の種類別市場規模（タイプ1、タイプ2）、用途別市場規模（病院、クリニック）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Abbott Laboratories、Glucox Biotech AB、Chugai Pharmaceutical、Johnson & Johnson、Stealth Peptides ・地域別グローバル市場分析 2015年-2020年 ・内皮機能不全の北米市場（アメリカ、カナダ、メキシコ） ・内皮機能不全のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・内皮機能不全のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・内皮機能不全の南米市場（ブラジル、アルゼンチン） ・内皮機能不全の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：タイプ1、タイプ2 ・用途別分析：病院、クリニック ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論

Market Overview
The global Endothelial Dysfunction market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Endothelial Dysfunction market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Endothelial Dysfunction market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Endothelial Dysfunction market has been segmented into:
Type 1
Type 2

By Application, Endothelial Dysfunction has been segmented into:
Hospital
Clinic

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Endothelial Dysfunction market presented in the report. This section sheds light on the sales growth of different regional and country-level Endothelial Dysfunction markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Endothelial Dysfunction market.

The report offers in-depth assessment of the growth and other aspects of the Endothelial Dysfunction market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Endothelial Dysfunction Market Share Analysis
Endothelial Dysfunction competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Endothelial Dysfunction sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Endothelial Dysfunction sales, revenue and market share for each player covered in this report.

The major players covered in Endothelial Dysfunction are:
Abbott Laboratories
Glucox Biotech AB
Chugai Pharmaceutical
Johnson & Johnson
Stealth Peptides

レポート目次

---

Table of Contents

1 Endothelial Dysfunction Market Overview
1.1 Product Overview and Scope of Endothelial Dysfunction
1.2 Classification of Endothelial Dysfunction by Type
1.2.1 Global Endothelial Dysfunction Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Endothelial Dysfunction Revenue Market Share by Type in 2019
1.2.3 Type 1
1.2.4 Type 2
1.3 Global Endothelial Dysfunction Market by Application
1.3.1 Overview: Global Endothelial Dysfunction Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Endothelial Dysfunction Market by Regions
1.4.1 Global Endothelial Dysfunction Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Endothelial Dysfunction (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Endothelial Dysfunction Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Endothelial Dysfunction Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Endothelial Dysfunction Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Endothelial Dysfunction Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Endothelial Dysfunction Status and Prospect (2015-2025)
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott Laboratories SWOT Analysis
2.1.4 Abbott Laboratories Product and Services
2.1.5 Abbott Laboratories Endothelial Dysfunction Revenue, Gross Margin and Market Share (2018-2019)
2.2 Glucox Biotech AB
2.2.1 Glucox Biotech AB Details
2.2.2 Glucox Biotech AB Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Glucox Biotech AB SWOT Analysis
2.2.4 Glucox Biotech AB Product and Services
2.2.5 Glucox Biotech AB Endothelial Dysfunction Revenue, Gross Margin and Market Share (2018-2019)
2.3 Chugai Pharmaceutical
2.3.1 Chugai Pharmaceutical Details
2.3.2 Chugai Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Chugai Pharmaceutical SWOT Analysis
2.3.4 Chugai Pharmaceutical Product and Services
2.3.5 Chugai Pharmaceutical Endothelial Dysfunction Revenue, Gross Margin and Market Share (2018-2019)
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Johnson & Johnson SWOT Analysis
2.4.4 Johnson & Johnson Product and Services
2.4.5 Johnson & Johnson Endothelial Dysfunction Revenue, Gross Margin and Market Share (2018-2019)
2.5 Stealth Peptides
2.5.1 Stealth Peptides Details
2.5.2 Stealth Peptides Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Stealth Peptides SWOT Analysis
2.5.4 Stealth Peptides Product and Services
2.5.5 Stealth Peptides Endothelial Dysfunction Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Endothelial Dysfunction Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Endothelial Dysfunction Players Market Share
3.2.2 Top 10 Endothelial Dysfunction Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Endothelial Dysfunction Revenue and Market Share by Regions
4.2 North America Endothelial Dysfunction Revenue and Growth Rate (2015-2020)
4.3 Europe Endothelial Dysfunction Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Endothelial Dysfunction Revenue and Growth Rate (2015-2020)
4.5 South America Endothelial Dysfunction Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Endothelial Dysfunction Revenue and Growth Rate (2015-2020)
5 North America Endothelial Dysfunction Revenue by Countries
5.1 North America Endothelial Dysfunction Revenue by Countries (2015-2020)
5.2 USA Endothelial Dysfunction Revenue and Growth Rate (2015-2020)
5.3 Canada Endothelial Dysfunction Revenue and Growth Rate (2015-2020)
5.4 Mexico Endothelial Dysfunction Revenue and Growth Rate (2015-2020)
6 Europe Endothelial Dysfunction Revenue by Countries
6.1 Europe Endothelial Dysfunction Revenue by Countries (2015-2020)
6.2 Germany Endothelial Dysfunction Revenue and Growth Rate (2015-2020)
6.3 UK Endothelial Dysfunction Revenue and Growth Rate (2015-2020)
6.4 France Endothelial Dysfunction Revenue and Growth Rate (2015-2020)
6.5 Russia Endothelial Dysfunction Revenue and Growth Rate (2015-2020)
6.6 Italy Endothelial Dysfunction Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Endothelial Dysfunction Revenue by Countries
7.1 Asia-Pacific Endothelial Dysfunction Revenue by Countries (2015-2020)
7.2 China Endothelial Dysfunction Revenue and Growth Rate (2015-2020)
7.3 Japan Endothelial Dysfunction Revenue and Growth Rate (2015-2020)
7.4 Korea Endothelial Dysfunction Revenue and Growth Rate (2015-2020)
7.5 India Endothelial Dysfunction Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Endothelial Dysfunction Revenue and Growth Rate (2015-2020)
8 South America Endothelial Dysfunction Revenue by Countries
8.1 South America Endothelial Dysfunction Revenue by Countries (2015-2020)
8.2 Brazil Endothelial Dysfunction Revenue and Growth Rate (2015-2020)
8.3 Argentina Endothelial Dysfunction Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Endothelial Dysfunction by Countries
9.1 Middle East & Africa Endothelial Dysfunction Revenue by Countries (2015-2020)
9.2 Saudi Arabia Endothelial Dysfunction Revenue and Growth Rate (2015-2020)
9.3 UAE Endothelial Dysfunction Revenue and Growth Rate (2015-2020)
9.4 Egypt Endothelial Dysfunction Revenue and Growth Rate (2015-2020)
9.5 South Africa Endothelial Dysfunction Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Endothelial Dysfunction Revenue and Market Share by Type (2015-2020)
10.2 Global Endothelial Dysfunction Market Forecast by Type (2019-2024)
10.3 Type 1 Revenue Growth Rate (2015-2025)
10.4 Type 2 Revenue Growth Rate (2015-2025)
11 Global Endothelial Dysfunction Market Segment by Application
11.1 Global Endothelial Dysfunction Revenue Market Share by Application (2015-2020)
11.2 Endothelial Dysfunction Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Clinic Revenue Growth (2015-2020)
12 Global Endothelial Dysfunction Market Size Forecast (2021-2025)
12.1 Global Endothelial Dysfunction Market Size Forecast (2021-2025)
12.2 Global Endothelial Dysfunction Market Forecast by Regions (2021-2025)
12.3 North America Endothelial Dysfunction Revenue Market Forecast (2021-2025)
12.4 Europe Endothelial Dysfunction Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Endothelial Dysfunction Revenue Market Forecast (2021-2025)
12.6 South America Endothelial Dysfunction Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Endothelial Dysfunction Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Endothelial Dysfunction Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Endothelial Dysfunction by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Endothelial Dysfunction Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Endothelial Dysfunction Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Abbott Laboratories Corporate Information, Location and Competitors
Table 6. Abbott Laboratories Endothelial Dysfunction Major Business
Table 7. Abbott Laboratories Endothelial Dysfunction Total Revenue (USD Million) (2017-2018)
Table 8. Abbott Laboratories SWOT Analysis
Table 9. Abbott Laboratories Endothelial Dysfunction Product and Solutions
Table 10. Abbott Laboratories Endothelial Dysfunction Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Glucox Biotech AB Corporate Information, Location and Competitors
Table 12. Glucox Biotech AB Endothelial Dysfunction Major Business
Table 13. Glucox Biotech AB Endothelial Dysfunction Total Revenue (USD Million) (2018-2019)
Table 14. Glucox Biotech AB SWOT Analysis
Table 15. Glucox Biotech AB Endothelial Dysfunction Product and Solutions
Table 16. Glucox Biotech AB Endothelial Dysfunction Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Chugai Pharmaceutical Corporate Information, Location and Competitors
Table 18. Chugai Pharmaceutical Endothelial Dysfunction Major Business
Table 19. Chugai Pharmaceutical Endothelial Dysfunction Total Revenue (USD Million) (2017-2018)
Table 20. Chugai Pharmaceutical SWOT Analysis
Table 21. Chugai Pharmaceutical Endothelial Dysfunction Product and Solutions
Table 22. Chugai Pharmaceutical Endothelial Dysfunction Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Johnson & Johnson Corporate Information, Location and Competitors
Table 24. Johnson & Johnson Endothelial Dysfunction Major Business
Table 25. Johnson & Johnson Endothelial Dysfunction Total Revenue (USD Million) (2017-2018)
Table 26. Johnson & Johnson SWOT Analysis
Table 27. Johnson & Johnson Endothelial Dysfunction Product and Solutions
Table 28. Johnson & Johnson Endothelial Dysfunction Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Stealth Peptides Corporate Information, Location and Competitors
Table 30. Stealth Peptides Endothelial Dysfunction Major Business
Table 31. Stealth Peptides Endothelial Dysfunction Total Revenue (USD Million) (2017-2018)
Table 32. Stealth Peptides SWOT Analysis
Table 33. Stealth Peptides Endothelial Dysfunction Product and Solutions
Table 34. Stealth Peptides Endothelial Dysfunction Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Global Endothelial Dysfunction Revenue (Million USD) by Players (2015-2020)
Table 36. Global Endothelial Dysfunction Revenue Share by Players (2015-2020)
Table 37. Global Endothelial Dysfunction Revenue (Million USD) by Regions (2015-2020)
Table 38. Global Endothelial Dysfunction Revenue Market Share by Regions (2015-2020)
Table 39. North America Endothelial Dysfunction Revenue by Countries (2015-2020)
Table 40. North America Endothelial Dysfunction Revenue Market Share by Countries (2015-2020)
Table 41. Europe Endothelial Dysfunction Revenue (Million USD) by Countries (2015-2020)
Table 42. Asia-Pacific Endothelial Dysfunction Revenue (Million USD) by Countries (2015-2020)
Table 43. South America Endothelial Dysfunction Revenue by Countries (2015-2020)
Table 44. South America Endothelial Dysfunction Revenue Market Share by Countries (2015-2020)
Table 45. Middle East and Africa Endothelial Dysfunction Revenue (Million USD) by Countries (2015-2020)
Table 46. Middle East and Africa Endothelial Dysfunction Revenue Market Share by Countries (2015-2020)
Table 47. Global Endothelial Dysfunction Revenue (Million USD) by Type (2015-2020)
Table 48. Global Endothelial Dysfunction Revenue Share by Type (2015-2020)
Table 49. Global Endothelial Dysfunction Revenue Forecast by Type (2021-2025)
Table 50. Global Endothelial Dysfunction Revenue by Application (2015-2020)
Table 51. Global Endothelial Dysfunction Revenue Share by Application (2015-2020)
Table 52. Global Endothelial Dysfunction Revenue Forecast by Application (2021-2025)
Table 53. Global Endothelial Dysfunction Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Endothelial Dysfunction Picture
Figure 2. Global Endothelial Dysfunction Revenue Market Share by Type in 2019
Figure 3. Type 1 Picture
Figure 4. Type 2 Picture
Figure 5. Endothelial Dysfunction Revenue Market Share by Application in 2019
Figure 6. Hospital Picture
Figure 7. Clinic Picture
Figure 8. Global Endothelial Dysfunction Revenue (USD Million) and Growth Rate (2015-2025)
Figure 9. North America Endothelial Dysfunction Revenue (Million USD) and Growth Rate (2015-2025)
Figure 10. Europe Endothelial Dysfunction Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Asia-Pacific Endothelial Dysfunction Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. South America Endothelial Dysfunction Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Middle East and Africa Endothelial Dysfunction Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Global Endothelial Dysfunction Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Endothelial Dysfunction Revenue Share by Players in 2019
Figure 16. Global Top 5 Players Endothelial Dysfunction Revenue Market Share in 2019
Figure 17. Global Top 10 Players Endothelial Dysfunction Revenue Market Share in 2019
Figure 18. Key Players Market Share Trend
Figure 19. Global Endothelial Dysfunction Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 20. Global Endothelial Dysfunction Revenue Market Share by Regions (2015-2020)
Figure 21. Global Endothelial Dysfunction Revenue Market Share by Regions in 2018
Figure 22. North America Endothelial Dysfunction Revenue and Growth Rate (2015-2020)
Figure 23. Europe Endothelial Dysfunction Revenue and Growth Rate (2015-2020)
Figure 24. Asia-Pacific Endothelial Dysfunction Revenue and Growth Rate (2015-2020)
Figure 25. South America Endothelial Dysfunction Revenue and Growth Rate (2015-2020)
Figure 26. Middle East and Africa Endothelial Dysfunction Revenue and Growth Rate (2015-2020)
Figure 27. North America Endothelial Dysfunction Revenue Market Share by Countries (2015-2020)
Figure 28. North America Endothelial Dysfunction Revenue Market Share by Countries in 2019
Figure 29. USA Endothelial Dysfunction Revenue and Growth Rate (2015-2020)
Figure 30. Canada Endothelial Dysfunction Revenue and Growth Rate (2015-2020)
Figure 31. Mexico Endothelial Dysfunction Revenue and Growth Rate (2015-2020)
Figure 32. Europe Endothelial Dysfunction Revenue Market Share by Countries (2015-2020)
Figure 33. Europe Endothelial Dysfunction Revenue Market Share by Countries in 2019
Figure 34. Germany Endothelial Dysfunction Revenue and Growth Rate (2015-2020)
Figure 35. UK Endothelial Dysfunction Revenue and Growth Rate (2015-2020)
Figure 36. France Endothelial Dysfunction Revenue and Growth Rate (2015-2020)
Figure 37. Russia Endothelial Dysfunction Revenue and Growth Rate (2015-2020)
Figure 38. Italy Endothelial Dysfunction Revenue and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Endothelial Dysfunction Revenue Market Share by Countries (2015-2020)
Figure 40. Asia-Pacific Endothelial Dysfunction Revenue Market Share by Countries in 2019
Figure 41. China Endothelial Dysfunction Revenue and Growth Rate (2015-2020)
Figure 42. Japan Endothelial Dysfunction Revenue and Growth Rate (2015-2020)
Figure 43. Korea Endothelial Dysfunction Revenue and Growth Rate (2015-2020)
Figure 44. India Endothelial Dysfunction Revenue and Growth Rate (2015-2020)
Figure 45. Southeast Asia Endothelial Dysfunction Revenue and Growth Rate (2015-2020)
Figure 46. South America Endothelial Dysfunction Revenue Market Share by Countries (2015-2020)
Figure 47. South America Endothelial Dysfunction Revenue Market Share by Countries in 2019
Figure 48. Brazil Endothelial Dysfunction Revenue and Growth Rate (2015-2020)
Figure 49. Argentina Endothelial Dysfunction Revenue and Growth Rate (2015-2020)
Figure 50. Middle East and Africa Endothelial Dysfunction Revenue Market Share by Countries (2015-2020)
Figure 51. Middle East and Africa Endothelial Dysfunction Revenue Market Share by Countries in 2019
Figure 52. Saudi Arabia Endothelial Dysfunction Revenue and Growth Rate (2015-2020)
Figure 53. UAE Endothelial Dysfunction Revenue and Growth Rate (2015-2020)
Figure 54. Egypt Endothelial Dysfunction Revenue and Growth Rate (2015-2020)
Figure 55. South Africa Endothelial Dysfunction Revenue and Growth Rate (2015-2020)
Figure 56. Global Endothelial Dysfunction Revenue Share by Type (2015-2020)
Figure 57. Global Endothelial Dysfunction Revenue Share by Type in 2019
Figure 58. Global Endothelial Dysfunction Market Share Forecast by Type (2021-2025)
Figure 59. Global Type 1 Revenue Growth Rate (2015-2020)
Figure 60. Global Type 2 Revenue Growth Rate (2015-2020)
Figure 61. Global Endothelial Dysfunction Revenue Share by Application (2015-2020)
Figure 62. Global Endothelial Dysfunction Revenue Share by Application in 2019
Figure 63. Global Endothelial Dysfunction Market Share Forecast by Application (2021-2025)
Figure 64. Global Hospital Revenue Growth Rate (2015-2020)
Figure 65. Global Clinic Revenue Growth Rate (2015-2020)
Figure 66. Global Endothelial Dysfunction Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 67. Global Endothelial Dysfunction Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 68. Global Endothelial Dysfunction Revenue Market Share Forecast by Regions (2021-2025)
Figure 69. North America Endothelial Dysfunction Revenue Market Forecast (2021-2025)
Figure 70. Europe Endothelial Dysfunction Revenue Market Forecast (2021-2025)
Figure 71. Asia-Pacific Endothelial Dysfunction Revenue Market Forecast (2021-2025)
Figure 72. South America Endothelial Dysfunction Revenue Market Forecast (2021-2025)
Figure 73. Middle East and Africa Endothelial Dysfunction Revenue Market Forecast (2021-2025)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel

---